Log In
BCIQ
Print this Print this
 

Natesto (formerly CompleoTRT, TBS-1)

  Manage Alerts
Collapse Summary General Information
Company Acerus Pharmaceuticals Corp.
DescriptionBioadhesive intranasal gel formulation of testosterone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism; Treat testosterone deficiency in men
Regulatory Designation U.S. - Standard Review (Treat hypogonadism);
U.S. - Standard Review (Treat testosterone deficiency in men)
PartnerEndo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$195.0M

$25.0M

$165.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/24/2014

$195.0M

$25.0M

$165.0M

Get a free BioCentury trial today